Diagnosis Ability of Dual-Phase F-18-fluoro-2-deoxy-D-glucose SPECT/PET for Distinguishing the Benign and Malignant Lesions
Rongfu Wang,Jianhua Zhang,Chunli Zhang,Yan Fan,Xuchu Zhang,Xiao-kun He,Fengqin Guo,Guangyu Zhao,Yan-Fu Wang,Hong Tian
2006-01-01
Journal of Nuclear Medicine
Abstract:652 Objectives: To evaluate the clinical diagnostic value of dual-phase 18F-fluoro-2-deoxy-D-glucose SPECT with coincidence using semi quantitative analysis and receiver operating characteristic curve (ROC) method for distinguishing the benign and malignant lesions. Methods: Thirty patients with unknown lesions were enrolled in this study. All patients underwent dual-phase 18F-FDG SPECT/PET. The early images were obtained at 60 min post injection. And the patients were divided into 2 groups, one received delayed scans at 210 min after 18F-FDG injection and the other at 270 min. Lesion status was determined by pathologic findings or by clinical follow-up. The results were analyzed by qualitative and semi quantitative methods. For all lesions, the ratio of tumor to no tumor (T/NT) activity and the retention index (RI) of dual-phase images were calculated. ROC with calculation of area under the curve (AUC) was used to evaluate diagnostic ability of early imaging, delayed imaging and RI, respectively. Results: Forty-eight lesions (30 malignant and 18 benign verified by pathologic findings or clinical follow-up) of 30 patients were detected by dual-phase imaging, in which there were 29 true positive results, 15 true negative, 3 false positive and 1 false negative. The sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value(NPV) of dual-phase imaging were 96.7%, 83.3%, 91.6%, 90.6%, and 93.8%, respectively. Those of early imaging and CT were 93.3%, 72.2%, 85.4%, 84.8%, 86.7% and 76.9%, 57.1%, 70.0%, 76.9%, 57.1%, respectively. The ratio of T/NT in all malignant lesions (except 1 false negative case) in delayed imaging were significantly increased (t=-3.071, P Conclusions: Dual-phase FDG-SPECT/PET provides benefit for differentiating benign from malignant lesions. And combined dual-phase imaging with ROC analytic method will improve the diagnostic specificity and accuracy.